What is LEVULANHCP.com?
LEVULANHCP.com specializes in advanced dermatological solutions, primarily focusing on the LEVULAN KERASTICK treatment. This therapy combines aminolevulinic acid HCl with BLU-U light to address minimally to moderately thick actinic keratosis. The company targets healthcare professionals seeking effective, innovative treatment options for their patients, providing comprehensive prescribing information and usage guidelines to ensure optimal therapeutic outcomes. Their commitment is to advance care in dermatological conditions.
How much funding has LEVULANHCP.com raised?
LEVULANHCP.com has raised a total of $24.8M across 1 funding round:
Private Equity
$24.8M
Private Equity (2004): $24.8M, investors not publicly disclosed
What's next for LEVULANHCP.com?
The recent major strategic investment signals a phase of potential expansion and further innovation for LEVULANHCP.com. This capital infusion is likely to support the scaling of their treatment offerings, enhance research and development into new dermatological applications, and potentially broaden their market reach within the healthcare professional community. The company appears poised to solidify its position as a key provider of specialized actinic keratosis therapies.
See full LEVULANHCP.com company page
